Loading...
Artrya Limited
AYA.AX•ASX
Healthcare
Medical - Healthcare Information Services
A$0.87
A$0.17(24.29%)
Artrya Limited (AYA.AX) Financial Performance & Statements
Review Artrya Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
-15.91%
↓ 15.91%
Net Income Growth
-25.72%
↓ 25.72%
Operating Cash Flow Growth
-43.48%
↓ 43.48%
Operating Margin
-57825.48%
↓ 57825.48%
Gross Margin
-30859.25%
↓ 30859.25%
Net Profit Margin
-112015.38%
↓ 112015.38%
ROE
-92.48%
↓ 92.48%
ROIC
-49.57%
↓ 49.57%
Artrya Limited (AYA.AX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Artrya Limited stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $9703.00 | $989000.00 | $301000.00 | $2967.00 |
| Gross Profit | -$9703.00 | -$989000.00 | -$301000.00 | -$2967.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $3073.00 | $1537.00 | $1276.00 | $1276.00 |
| SG&A Expenses | $333.00 | $7.92M | $5.01M | $310.00 |
| Operating Expenses | -$2390.00 | $7.92M | $5.00M | $508.00 |
| Total Costs & Expenses | $7313.00 | $8.91M | $5.30M | $3475.00 |
| Interest Income | $384000.00 | $266000.00 | $276000.00 | $123.00 |
| Interest Expense | $0.00 | $35000.00 | $31000.00 | $0.00 |
| Depreciation & Amortization | $2.01M | $989000.00 | $301000.00 | $74.00 |
| EBITDA | -$12.23M | -$5.83M | -$4.34M | -$2.38M |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$7313.00 | -$8.91M | -$5.30M | -$2454.00 |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | $196.00 | $115500.00 | $2.96M | $122500.00 |
| Income Before Tax | -$7117.00 | -$6.86M | -$4.67M | -$2336.00 |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $4.00 | $23000.00 | $6000.00 | $3.00 |
| Net Income | -$7.12M | -$3.44M | -$2.34M | -$2.34M |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | $0.00 | -$0.04 | -$0.03 | -$0.03 |
| Diluted EPS | $0.00 | -$0.04 | -$0.03 | -$0.03 |
| Weighted Avg Shares Outstanding | $78.68M | $78.61M | $78.33M | $78.33M |
| Weighted Avg Shares Outstanding (Diluted) | $78.67M | $78.61M | $78.42M | $78.42M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan